Literature DB >> 3242575

Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease.

C R Swinburn1, J M Wakefield, S P Newman, P W Jones.   

Abstract

1. It is a clinical impression that some patients given oral corticosteroids develop a sense of wellbeing that is 'inappropriate' to improvements in physical health. This has been termed steroid 'euphoria', but unlike steroid-induced psychosis it has not been documented. 2. To test for the size and frequency of this phenomenon, 20 patients with severe chronic obstructive airways disease (mean FEV1 0.86 l) were given 30 mg of prednisolone for 14 days, after a period of placebo administration in a single-blind study. 3. Lung spirometry and arterial saturation during exercise were measured serially, together with established measures of mood state. 4. No changes in spirometry or arterial saturation during exercise were detected until 7 days of active therapy. 5. Mood state did not change during the placebo period, but small significant reductions in anxiety and depression were measured after 3 days of prednisolone and before any measurable improvement in lung function. Mood state did not then further improve, despite measurable improvements in lung spirometry. 6. This is evidence that prednisolone may produce a mild 'inappropriate' sense of wellbeing within a population receiving the drug, rather than as an occasional idiosyncratic response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3242575      PMCID: PMC1386585          DOI: 10.1111/j.1365-2125.1988.tb05309.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  BRONCHODILATORS AND CORTICOSTEROIDS IN CHRONIC BRONCHITIS AND EMPHYSEMA.

Authors:  B J FREEDMAN
Journal:  Br Med J       Date:  1963-12-14

3.  AN ANALYSIS OF MOOD IN NEUROTICS.

Authors:  D M MCNAIR; M LORR
Journal:  J Abnorm Psychol       Date:  1964-12

4.  The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population.

Authors:  C M FLETCHER; P C ELMES; A S FAIRBAIRN; C H WOOD
Journal:  Br Med J       Date:  1959-08-29

5.  Clinical improvement after treatment with prednisolone in chronic airways obstruction in absence of change in lung function tests.

Authors:  C R Swinburn; J M Wakefield; P W Jones
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

6.  Use of multivariate measures of disability in health surveys.

Authors:  J R Charlton; D L Patrick; H Peach
Journal:  J Epidemiol Community Health       Date:  1983-12       Impact factor: 3.710

7.  Side effects of corticosteroid therapy. Psychiatric aspects.

Authors:  M H Ling; P J Perry; M T Tsuang
Journal:  Arch Gen Psychiatry       Date:  1981-04

8.  Some norms and reliability data for the State--Trait Anxiety Inventory and the Zung Self-Rating Depression scale.

Authors:  R G Knight; H J Waal-Manning; G F Spears
Journal:  Br J Clin Psychol       Date:  1983-11

9.  Prevalence by Self-report questionnaire and recognition by nonpsychiatric physicians.

Authors:  A C Nielsen; T A Williams
Journal:  Arch Gen Psychiatry       Date:  1980-09

10.  Psychological changes and improvement in chronic airflow limitation after corticosteroid treatment.

Authors:  D M Mitchell; P Gildeh; M Rehahn; A Dimond; J V Collins
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

  10 in total
  9 in total

Review 1.  Quality of life measurement for patients with diseases of the airways.

Authors:  P W Jones
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

2.  Short-term glucocorticoid intake improves exercise endurance in healthy recreationally trained women.

Authors:  Bénédicte Le Panse; Rémi Thomasson; Laetitia Jollin; Anne-Marie Lecoq; Virgile Amiot; Nathalie Rieth; Jacques De Ceaurriz; Katia Collomp
Journal:  Eur J Appl Physiol       Date:  2009-08-11       Impact factor: 3.078

Review 3.  Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.

Authors:  S B Patten; C I Neutel
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

4.  Altered leucocyte trafficking and suppressed tumour necrosis factor alpha release from peripheral blood monocytes after intra-articular glucocorticoid treatment.

Authors:  J H Steer; D T Ma; L Dusci; G Garas; K E Pedersen; D A Joyce
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

5.  Glucocorticoids improve high-intensity exercise performance in humans.

Authors:  Rafael A Casuso; Lars Melskens; Thomas Bruhn; Niels H Secher; Nikolai Baastrup Nordsborg
Journal:  Eur J Appl Physiol       Date:  2013-12-11       Impact factor: 3.078

6.  Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD.

Authors:  S L Karlsson; V Backer; Nina Skavlan Godtfredsen
Journal:  Chron Respir Dis       Date:  2017-07-18       Impact factor: 2.444

7.  Rate of Corticosteroid-Induced Mood Changes in Patients with Inflammatory Bowel Disease: A Prospective Study.

Authors:  George Ou; Brian Bressler; Cherry Galorport; Eric Lam; Hin Hin Ko; Robert Enns; Jennifer Telford; Nathan Schaffer; Terry Lee; Greg Rosenfeld
Journal:  J Can Assoc Gastroenterol       Date:  2018-06-04

8.  A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.

Authors:  Dora Liu; Alexandra Ahmet; Leanne Ward; Preetha Krishnamoorthy; Efrem D Mandelcorn; Richard Leigh; Jacques P Brown; Albert Cohen; Harold Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2013-08-15       Impact factor: 3.406

9.  Corticosteroid-related central nervous system side effects.

Authors:  Miriam Ciriaco; Pasquale Ventrice; Gaetano Russo; Maria Scicchitano; Giovanni Mazzitello; Francesca Scicchitano; Emilio Russo
Journal:  J Pharmacol Pharmacother       Date:  2013-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.